Here, we show that ERK5 is significantly upregulated in solid lung tumor growth progression and potently promotes cell proliferation and cell cycle progression in A549 lung adenocarcinoma, at least in part by upregulating cyclin B1, which is an essential modulator in controlling G2/M phase transition. This evidence concerns the gene CCNB1 and lung adenocarcinoma.